Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 5/2011

01-07-2011 | Original Paper

Social Networks of PLHA in Uganda: Implications for Mobilizing PLHA as Agents for Prevention

Authors: Harold D. Green Jr., Lynn Atuyambe, Sarah Ssali, Gery W. Ryan, Glenn J. Wagner

Published in: AIDS and Behavior | Issue 5/2011

Login to get access

Abstract

The objective of this study was to describe the social networks of people living with HIV/AIDS (PLHA) and explore the implications social network characteristics might have for mobilizing PLHA as prevention agents. Thirty-nine PLHA attending an HIV clinic in Kampala, Uganda provided information on themselves and on 20 network members. Based on these data, descriptive statistics for social network composition and structure were calculated. Research questions relating these network characteristics to treatment-related variables such as time since diagnosis, ART status, and time on ART were investigated. Analyses reveal that, in general, network members know the PLHA’s status, are trusted, provide advice and support, and are well-connected to each other. Network features (e.g., proportion of individuals who know the PLHA’s status) are related to the previously mentioned treatment variables. Findings suggest that PLHA surround themselves with a social context that enables PLHA to feel fairly protected and supported if they choose to discuss HIV and prevention. With respect to treatment, those on ART may be better prepared to act as prevention advocates.
Literature
1.
Knowlton AR, Hua W, Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 2005;17(4):479–92.PubMedCrossRef
2.
Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995;38(1):1–9.PubMedCrossRef
3.
Potterat JJ, Rothenberg RB, Muth SQ. Network structural dynamics and infectious disease propagation. Int J STD AIDS. 1999;10(3):182–5.PubMedCrossRef
4.
Rothenberg RB, Potterat JJ, Woodhouse DE, et al. Social network dynamics and HIV transmission. AIDS. 1998;12(12):1529–36.PubMedCrossRef
5.
el-Bassel N, Chen DR, Cooper D. Social support and social network profiles among women on methadone. Soc Serv Rev. 1998;72:379–401.CrossRef
6.
el-Bassel N, Cooper DK, Chen DR, Schilling RF. Personal social networks and HIV status among women on methadone. AIDS Care. 1998;10(6):735–49.PubMedCrossRef
7.
Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE study. Am J Community Psychol. 2006;24(3):341–64.CrossRef
8.
Montgomery SB, Hyde J, De Rosa CJ, Rohrbach LA, Ennett S, Harvey SM, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002;28(3):453–75.PubMedCrossRef
9.
Latkin CA, Forman V, Knowlton A, Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56:465–76.PubMedCrossRef
10.
Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, Nicholas PK, et al. Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa. Int J Nurs Stud. 2008;45(12):1757–63.PubMedCrossRef
11.
Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006;1(43 Suppl 1):S127–33.
12.
Campero L, Herrera C, Kendall T, Caballero M. Bridging the gap between antiretroviral access and adherence in Mexico. Qual Health Res. 2007;17(5):599–611.PubMedCrossRef
13.
Heaney CA, Israel BA. Social networks and social support. In: Glanz K, Lewis FM, Rimer BK, editors. Social networks and social support in health behavior and health education theory, research, and practice. San Francisco, CA: Jossey-Bass; 2002.
14.
Valente TW, Fosados R. Diffusion of innovations and network segmentation: the part played by people in promoting health. Sex Transm Dis. 2006;33(7 Suppl):S23–31.PubMed
15.
Cialdini RB, Trost MR. Social influence: social norms, conformity, and compliance. In: Gilbert DT, Fiske ST, Lindzey G, editors. The handbook of social psychology. 4th ed. Boston, MA: McGraw-Hill; 1998. p. 151–92.
16.
Ajzen I, Fishbein M. Attitudes and normative beliefs as factors influencing behavioral intentions in hypothetical situations involving risk. J Pers Soc Psychol. 1972;21:1–9.CrossRef
17.
Bandura A, Walters RH. Social learning and personality development. New York, NY: Holt, Rinehart & Winston; 1963.
18.
Pickett CL, Gardner WL. The social monitoring system: enhanced sensitivity to social cues and information as an adaptive response to social exclusion and belonging need. In: Williams K, Forgas J, von Hippel W, editors. The social outcast: ostracism, social exclusion, rejection, and bullying. New York, NY: Psychology Press; 2005. p. 213–26.
19.
Kelly RB, Zyzanski SJ, Alemagno SA. Prediction of motivation and behavior change following health promotion: role of health beliefs, social support, and self-efficacy. Soc Sci Med. 1991;32(3):311–20.PubMedCrossRef
20.
Burns TR, Dietz T. Cultural evolution: social rule systems, selection and human agency. Int Sociol. 1992;7(3):259–83.CrossRef
21.
Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.PubMedCrossRef
22.
Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.PubMedCrossRef
23.
Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9(2):135–43.PubMedCrossRef
24.
Campbell K, Lee B. Name generators in surveys of personal networks. Soc Networks. 1991;13:203–21.CrossRef
25.
McCarty C. Measuring structure in personal networks. J Soc Struct. 2002;3:1.
26.
McCarty C, Bernard H, Killworth P, Shelley GA, Johnsen EC. Eliciting representative samples of personal networks. Soc Networks. 1997;19:303–23.CrossRef
27.
McCarty C, Kilworth PD, Rennell J. Impact of methods for reducing respondent burden on personal network structural measures. Soc Networks. 2007;29(2):300–15.CrossRef
28.
Wasserman S, Faust KB. social network analysis: methods and applications. New York, NY: Cambridge University Press; 1994.
29.
Kamada T, Kawai S. An algorithm for drawing general, undirected graphs. Inf Process Lett. 1989;31(1):7–15.CrossRef
30.
Ntozi JPM, Nakayiwa S. AIDS in Uganda: how has the household coped with the epidemic? In: Caldwell JC, Orubuloye IO, Ntozi JPM, editors. The continuing African HIV/AIDS epidemic. Canberra, Australia: Health Transition Centre, National Centre for Epidemiology and Population Health, Australian National University; 1999. p. 155–181.
31.
King R, Katuntu D, Lifshay J, Packel L, Batamwita R, Nakayiwa S, et al. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav. 2008;12(2):232–43.PubMedCrossRef
32.
Kaleeba N, Kalibala S, Kaseje M, Ssebbanja P, Anderson S, van Praag E, et al. Participatory evaluation of counseling, medical and social services of the AIDS support organization (TASO) in Uganda. AIDS Care. 1997;9(1):13–26.PubMedCrossRef
33.
Maman S, Abler L, Parker L, Lane T, Chirowodza A, Ntogwisangu J, et al. A comparison of HIV stigma and discrimination in five international sites: the influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009;68:2271–8.PubMedCrossRef
34.
Maughan-Brown B. Stigma rises despite antiretroviral roll-out: a longitudinal analysis in South Africa. Soc Sci Med. 2009 [Epub ahead of print].
35.
Tracy EM, Whittaker JK. The social network map: assessing social support in clinical practice. Fam Soc. 1990;71(8):461–70.
36.
Rempel GR, Neufeld A, Kushner KE. Interactive use of genograms and ecomaps in family caregiving research. J Fam Nurs. 2007;13(4):403–19.PubMedCrossRef
37.
Kelly JA. Popular opinion leaders and HIV prevention peer education: resolving discrepant findings, and implications for the development of effective community programs. AIDS Care. 2004;16:139–50.PubMedCrossRef
Metadata
Title
Social Networks of PLHA in Uganda: Implications for Mobilizing PLHA as Agents for Prevention
Authors
Harold D. Green Jr.
Lynn Atuyambe
Sarah Ssali
Gery W. Ryan
Glenn J. Wagner
Publication date
01-07-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9707-y

Other articles of this Issue 5/2011

AIDS and Behavior 5/2011 Go to the issue

Original Paper

HIV Prevention Among African American Youth: How Well Have Evidence-Based Interventions Addressed Key Theoretical Constructs?

Original Paper

Application of the Attitude-Social Influence-Efficacy Model to Condom Use Among African-American STD Clinic Patients: Implications for Tailored Health Communication

Original Paper

Possible Increase in HIV and Syphilis Prevalence Among Men Who Have Sex with Men in Guangzhou, China: Results from a Respondent-Driven Sampling Survey

Original Paper

Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability

Original Paper

Sexual Risk Taking, STI and HIV Prevalence Among Men Who Have Sex with Men in Six Indonesian Cities

Original Paper

Crossing Over: Drug Network Characteristics and Injection Risk Along the China–Myanmar Border
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits